Patrik Zintl

is working from home. 🏡

Angestellt, Executive Director Medical Affairs, BeiGene

Zug, Schweiz

Fähigkeiten und Kenntnisse

19 years working experience in oncology drug devel
Start-up role for new clinical and medical departm
Project Leader for drug development program
Global Project Management of Phase I to III
Late phase development including Market Access dos
Evaluating business development in-license product
Leading role in oncology drug approvals indication
Global Key opinion leader management
Leading Medical Affairs department Strengths: Stro
Accustomed to office and department start up activ
Languages: Fluent English
German
Spanish
Intermediate in French
Specialties: Drug development from preclinical to
KOL management; Advisory Boards
Satellite Symposia and international congress prep
Sales team trainer; coordinator of international M

Werdegang

Berufserfahrung von Patrik Zintl

  • Bis heute 4 Jahre und 8 Monate, seit Nov. 2019

    Executive Director Medical Affairs

    BeiGene

  • 7 Monate, Apr. 2019 - Okt. 2019

    Global Medical Director - Medical Affairs

    GSK-Tesaro

    Global medical strategy, Zejula brand team member

  • 2 Jahre und 8 Monate, Sep. 2016 - Apr. 2019

    International Medical Director - Medical Affairs

    Tesaro

    International brand team member, launch plan preparation

  • 3 Jahre und 9 Monate, 2013 - Sep. 2016

    Director EU MSLs and Scientific Operations, Medical Affairs Europe

    Cell Therapeutics Inc. Life Sciences

  • 5 Jahre und 5 Monate, Sep. 2007 - Jan. 2013

    International Associate Director Operations (Med. Affairs)

    PharmaMar

    Responsible for Project Management of Phase I to late phase studies. Clinical projects including reimbursement studies and Market Access dossiers. Leading team of project physicians and Medical Scientific Liaisons based in EU countries, Start up of Medical Affairs department after drug approval,

  • 6 Jahre und 1 Monat, Sep. 2001 - Sep. 2007

    Supervisor Clinical Department US / Global Project Management

    Pharma Mar SAU, Madrid-Boston

    -Startup of new operational office including the clinical development department USA. Responsible for all US incoming contacts regarding investigational drugs; Manager of global multi-center Phase I, II / Phase III oncology trials. Worldwide projects including 21 countries in AsiaPac, LAM, NAM, EU, ROW with emerging countries, Oncology drug development Project Leader for company as main contact with international business development partner

  • 1995 - 2001

    Project Manager / CRA

    PRA-International / IBAH EuroBiopharm / Omnicare (LCRA)

Ausbildung von Patrik Zintl

  • 7 Jahre und 9 Monate, Sep. 1979 - Mai 1987

    AKG Bensheim

  • Biochemistry, Biology

    University Heidelberg, UCC-Cork Ireland

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Spanisch

    Fließend

  • Französisch

    Gut

Interessen

Sport: MTBike
Ski
Diving
Trekking

21 Mio. XING Mitglieder, von A bis Z

Nachname:

ABCDEFGHIJKLMNOP
QRSTUVWXYZ